Epithelial-Mesenchymal Transition Phenotype, Metformin, and Survival for Colorectal Cancer Patients with Diabetes Mellitus II
Objectives. We aimed to explore the association between metformin treatment and epithelial-mesenchymal transition (EMT) phenotype and further appraise the prognostic values of metformin and EMT markers E-cadherin and vimentin for colorectal cancer (CRC) in clinical practice. Methods. We collected sp...
Saved in:
Main Authors: | Yaodu Wang, Zhiyang Wu, Likuan Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2017/2520581 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Survival Analysis of Diabetic Colorectal Cancer Patients on Metformin
by: Alex Brandon Wong, et al.
Published: (2023-12-01) -
Opioid System and Epithelial–Mesenchymal Transition
by: Marzena Łazarczyk, et al.
Published: (2025-01-01) -
Nonylphenol promotes epithelial-mesenchymal transition in colorectal cancer cells by upregulating miR-151a-3p
by: Biao Wang, et al.
Published: (2025-01-01) -
Epithelial mesenchymal transition in human menstruation and implantation
by: Hiroshi Uchida
Published: (2024-08-01) -
Exploring the Crosstalk between Inflammation and Epithelial-Mesenchymal Transition in Cancer
by: Indranil Chattopadhyay, et al.
Published: (2021-01-01)